• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血后凝血因子功能亢进诱发深静脉血栓形成。

Coagulation Factor Hyperfunction After Subarachnoid Hemorrhage Induces Deep Venous Thrombosis.

作者信息

Miao Wang, Zhao Ke, Deng Wenjing, Teng Junfang

机构信息

First Affiliated Hospital of Zhengzhou University, Department of Neurology, Zhengzhou, People's Republic of China.

First Affiliated Hospital of Zhengzhou University, Department of Neurology, Zhengzhou, People's Republic of China.

出版信息

World Neurosurg. 2018 Feb;110:e46-e52. doi: 10.1016/j.wneu.2017.09.200. Epub 2017 Nov 28.

DOI:10.1016/j.wneu.2017.09.200
PMID:29196248
Abstract

OBJECTIVE

To explore the change of coagulation function and associated potential mechanisms and the relationship between coagulation disorders and deep venous thrombosis (DVT) after subarachnoid hemorrhage (SAH) within 3 days of onset.

METHODS

A total of 150 patients with SAH within 3 days of onset and 100 healthy individuals were recruited. Thrombelastography analysis and traditional laboratory tests were performed. Tissue factor (TF), tissue factor pathway inhibitor (TFPI) and activated protein C (APC) were tested by using enzyme-linked immunoassay kits. Extremities of patients with SAH were scanned by Doppler ultrasonography. Subgroup analysis was performed in patients with SAH based on the presence or lack of DVT.

RESULTS

Compared with control groups, R (an indicator of coagulation factor function in thrombelastography) was significantly decreased (4.32 ± 0.99 minutes vs. 6.00 ± 0.75 minutes; P < 0.001), especially in patients with DVT. TF was significantly increased (20.84 ± 4.15 pg/mL vs. 5.24 ± 1.86 pg/mL; P < 0.001). TFPI was decreased (50.42 ± 5.81 ng/mL vs. 64.10 ± 6.04 ng/mL). APC had no apparent changes. R was negatively correlated with TF (r = 0.358; P < 0.05) and positively correlated with TFPI (r = 0.325; P < 0.05) and APC (r = 0.162; P < 0.05). TF, TFPI, and APC had the same variation characteristics in the DVT subgroup compared with the no DVT subgroup. DVT was associated with R through association analysis (r = 0.369; P < 0.05). The R cutoff value for estimating the presence of DVT was 3.65 minutes.

CONCLUSIONS

Coagulation factor hyperfunction may be mainly accompanied within 3 days of SAH onset and may induce DVT. This situation may be associated with TF-TFPI-APC imbalance. R = 3.65 minutes was a potential intervention point to prevent the risk of DVT in this population.

摘要

目的

探讨蛛网膜下腔出血(SAH)发病3天内凝血功能的变化及其相关潜在机制,以及凝血功能障碍与深静脉血栓形成(DVT)之间的关系。

方法

招募150例发病3天内的SAH患者和100名健康个体。进行血栓弹力图分析和传统实验室检查。使用酶联免疫分析试剂盒检测组织因子(TF)、组织因子途径抑制剂(TFPI)和活化蛋白C(APC)。对SAH患者的四肢进行多普勒超声扫描。根据是否存在DVT对SAH患者进行亚组分析。

结果

与对照组相比,R(血栓弹力图中凝血因子功能指标)显著降低(4.32±0.99分钟 vs. 6.00±0.75分钟;P<0.001),尤其是在DVT患者中。TF显著升高(20.84±4.15 pg/mL vs. 5.24±1.86 pg/mL;P<0.001)。TFPI降低(50.42±5.81 ng/mL vs. 64.10±6.04 ng/mL)。APC无明显变化。R与TF呈负相关(r = 0.358;P<0.05),与TFPI呈正相关(r = 0.325;P<0.05),与APC呈正相关(r = 0.162;P<0.05)。与无DVT亚组相比,DVT亚组中TF、TFPI和APC具有相同的变化特征。通过关联分析,DVT与R相关(r = 0.369;P<0.05)。估计DVT存在的R临界值为3.65分钟。

结论

SAH发病3天内可能主要伴有凝血因子功能亢进,并可能诱发DVT。这种情况可能与TF-TFPI-APC失衡有关。R = 3.65分钟是预防该人群DVT风险的潜在干预点。

相似文献

1
Coagulation Factor Hyperfunction After Subarachnoid Hemorrhage Induces Deep Venous Thrombosis.蛛网膜下腔出血后凝血因子功能亢进诱发深静脉血栓形成。
World Neurosurg. 2018 Feb;110:e46-e52. doi: 10.1016/j.wneu.2017.09.200. Epub 2017 Nov 28.
2
The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.新型组织因子途径抑制剂功能测定对预测创伤患者深静脉血栓形成的抗凝活性的影响:一项前瞻性巢式病例对照研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211063877. doi: 10.1177/10760296211063877.
3
Incidence of deep venous thrombosis after subarachnoid hemorrhage.蛛网膜下腔出血后深静脉血栓形成的发生率。
J Neurosurg. 2009 May;110(5):1010-4. doi: 10.3171/2008.9.JNS08107.
4
Tissue Factor Pathway Inhibitor-1 Is a Valuable Marker for the Prediction of Deep Venous Thrombosis and Tumor Metastasis in Patients with Lung Cancer.组织因子途径抑制物-1是预测肺癌患者深静脉血栓形成和肿瘤转移的重要标志物。
Biomed Res Int. 2017;2017:8983763. doi: 10.1155/2017/8983763. Epub 2017 Jan 26.
5
Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.组织因子、组织途径因子抑制剂与慢性肢体缺血患者动脉粥样硬化的危险因素:初步研究
Int Angiol. 2008 Aug;27(4):296-301.
6
Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.组织因子途径抑制物基因及抗原水平与静脉血栓形成的相关性分析
Br J Haematol. 2001 May;113(2):537-43. doi: 10.1046/j.1365-2141.2001.02752.x.
7
Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.急性特发性深静脉血栓形成患者及随访一年期间微粒相关组织因子活性
Thromb Res. 2014 Nov;134(5):1093-6. doi: 10.1016/j.thromres.2014.07.041. Epub 2014 Aug 22.
8
The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.组织因子途径抑制剂对通过血栓弹力图测定的凝血动力学的影响。
Anesth Analg. 2006 Oct;103(4):841-5. doi: 10.1213/01.ane.0000237285.40106.1e.
9
The tissue factor pathway mediates both activation of coagulation and coagulopathy after injury.组织因子途径介导损伤后的凝血激活及凝血病。
J Trauma Acute Care Surg. 2015 Dec;79(6):1009-13; discussion 1014. doi: 10.1097/TA.0000000000000707.
10
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.缺血性心脏病患者体内组织因子及组织因子途径抑制物循环水平升高。
Thromb Haemost. 1998 Mar;79(3):495-9.

引用本文的文献

1
Preoperative coagulation parameters predict postoperative bleeding after endovascular treatment of intracranial aneurysms: A retrospective cohort study.术前凝血参数可预测颅内动脉瘤血管内治疗术后出血:一项回顾性队列研究。
J Int Med Res. 2025 Sep;53(9):3000605251379524. doi: 10.1177/03000605251379524. Epub 2025 Sep 24.
2
The Role of Nursing Care in the Management of Patients with Traumatic Subarachnoid Hemorrhage.护理在创伤性蛛网膜下腔出血患者管理中的作用
Galen Med J. 2023 Aug 20;12:e3013. doi: 10.31661/gmj.v12i0.3013. eCollection 2023.
3
Construction and validation of a perioperative concomitant lower extremity deep vein thrombosis line graph model in patients with aneurysmal subarachnoid hemorrhage.
动脉瘤性蛛网膜下腔出血患者围手术期并发下肢深静脉血栓形成线性图模型的构建与验证
Heliyon. 2024 Mar 9;10(5):e27415. doi: 10.1016/j.heliyon.2024.e27415. eCollection 2024 Mar 15.
4
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance.脑出血患者深静脉血栓形成早期预防的实施:来自中国卒中中心联盟的一项观察性研究
Thromb J. 2024 Feb 28;22(1):22. doi: 10.1186/s12959-024-00592-w.
5
Development of a predictive nomogram for 28-day mortality risk in non-traumatic or post-traumatic subarachnoid hemorrhage patients.开发一种用于预测非创伤性或创伤性蛛网膜下腔出血患者 28 天死亡率风险的预测列线图。
Neurol Sci. 2024 May;45(5):2149-2163. doi: 10.1007/s10072-023-07199-5. Epub 2023 Nov 23.
6
Knockdown of lncRNA XIST Ameliorates IL-1-Induced Apoptosis of HUVECs and Change of Tissue Factor Level via miR-103a-3p/HMGB1 Axis in Deep Venous Thrombosis by Regulating the ROS/NF-B Signaling Pathway.lncRNA XIST 敲低通过调控 ROS/NF-κB 信号通路改善深静脉血栓形成中 IL-1 诱导的 HUVECs 凋亡及组织因子水平的改变
Cardiovasc Ther. 2022 Nov 18;2022:6256384. doi: 10.1155/2022/6256384. eCollection 2022.
7
A novel risk score to predict deep vein thrombosis after spontaneous intracerebral hemorrhage.一种预测自发性脑出血后深静脉血栓形成的新型风险评分。
Front Neurol. 2022 Oct 28;13:930500. doi: 10.3389/fneur.2022.930500. eCollection 2022.
8
Predictors of deep-vein thrombosis in subarachnoid hemorrhage: a retrospective analysis.蛛网膜下腔出血中深静脉血栓形成的预测因素:一项回顾性分析。
Acta Neurochir (Wien). 2020 Sep;162(9):2295-2301. doi: 10.1007/s00701-020-04455-x. Epub 2020 Jun 23.